Carl Zeiss Meditec (AFX.DE)

Executive Summary

Carl Zeiss Meditec is a global leader in ophthalmic and microsurgical medical devices, offering precision-engineered solutions for diagnostics, surgery, and digital workflows. The company's strong portfolio includes surgical microscopes, intraocular lenses, and diagnostic imaging systems, positioning it to benefit from an aging population and rising demand for vision care. Despite near-term headwinds from currency effects and supply chain disruptions, Zeiss Meditec maintains robust R&D investments and a focus on innovation, particularly in digital surgery and AI-assisted diagnostics. The company's diversified business and recurring revenue from consumables provide stability, while its strategic partnerships and presence in emerging markets offer growth opportunities. However, competition from Alcon and Bausch + Lomb remains intense.

Upcoming Catalysts (preview)

• H2 2026Launch of next-generation digital surgical microscope platform75% success
• Q1 2027Fiscal year 2026 earnings and outlook update95% success